The report "Bunion Surgery Market by Product (Correction Systems, Implants & Accessories), Patient Type (Adult, Pediatric), Type (Minimally Invasive Surgery, Traditional Surgery), End User (Hospitals, ASCs, Orthopedic Clinics), Region - Global Forecast to 2029", is valued at an estimated USD 458.4 million in 2024 and is projected to reach USD 606.1 million by 2029 at a CAGR of 5.7% during the forecast period.
Browse 240 market data Tables and 49 Figures spread through 234 Pages and in-depth TOC on "Bunion Surgery Market by Product (Correction Systems, Implants & Accessories), Patient Type (Adult, Pediatric), Type (Minimally Invasive Surgery, Traditional Surgery), End User (Hospitals, ASCs, Orthopedic Clinics), Region - Global Forecast to 2029"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/bunion-surgery-market-13126931.html
Several key factors are driving growth of the bunion surgery market such as changing lifestyles, including the use of improper footwear, which leads to the development of a bunion and are associated with an increased prevalence of bunions and a rising demand for surgical treatment. An increase in sports injuries, mainly from running, which causes stress on the feet, is another factor contributing to the growing need for bunion surgery. Moreover, the increasing adoption of minimally invasive surgery, along with benefits such as shorter hospital stay, less pain, and quicker recovery time, is further driving growth in the market. Moreover, advancements in surgical systems with improved features and rising prevalence of arthritis are also acting as significant contributors to the growing bunion surgery market.
In 2023, the implants & accessories segment held the largest market share of bunion surgery market by product.
Categorized by product, the bunion surgery market is segmented into correction systems and implants & accessories. The largest share of bunion surgery market was held by the implants & accessories segment in 2023. With an increased prevalence of bunions, more patients are opting for surgical treatment, which, in most cases, comprises the use of implants & accessories like plates, staples, and screws. These devices are importance in stabilizing the bones and ensuring proper alignment during the recovery process. The need for more effective solutions, along with developments in implants & accessories technology, have led to the dominance of this segment in the market.
The traditional surgeries segment dominated the bunion surgery market by type in 2023.
The market is divided into traditional surgeries and minimally invasive surgeries, of which traditional surgery holds the largest share due to its proven efficacy and a long record of successful outcomes, especially in cases of severe bunion deformity or complex deformity that cannot be treated by minimally invasive surgical procedures. In addition, the increasing cases of arthritis also make more considerable bunion deformities, thus also driving the requirement for traditional surgeries.
North America is the largest regional market for bunion surgery market.
The market for bunion surgery has been segmented into six primary geographical regions, that include North America, Europe, Asia Pacific, Latin America, Middle East & Africa and GCC Countries. In 2023, the North America held the dominant share of the bunion surgery market. The bunion surgery market in North America is the biggest regional market, mainly due to the fact that developed healthcare systems prevail in this region, such as in the US and Canada. Apart from this, the aging population, combined with the increasing prevalence of diseases such as arthritis, further adds to the incidence of bunion deformities, hence increasing the demand for surgical treatments. In addition, the region has robust insurance coverage and reimbursement policies that makes surgical treatments more accessible to patients.
The major players operating in this market are Stryker (US), Johnson & Johnson Services, Inc. (US), Smith+Nephew (UK), Paragon 28, Inc (US), Zimmer Biomet (US), CONMED Corporation (US), Enovis Corporation (US), Medartis AG (Switzerland), Treace Medical Concepts, Inc (US), and Arthrex, Inc. (US).
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com